Abstract Purpose of Review The utility of aspirin and statins for primary prevention of
atherosclerotic cardiovascular disease remains ambiguous in older adults. Current …

The value of primary preventative therapies for cardiovascular disease (CVD) in older adults
(age≥ 75 years) is less certain than in younger patients. There is a lack of quality evidence …

Objective Personalizing preventive therapies for atherosclerotic cardiovascular disease
(ASCVD) is particularly important for older adults, as they tend to have multiple chronic …

Primary prevention of cardiovascular events in older adults is challenging because of a
general paucity of evidence for safe and efficacious therapy. Furthermore, there is no …

Background and Purpose Evidence for statin use for primary cardiovascular disease
prevention in older adults is limited. When evidence on risk-benefit profile of a medication is …

The burden of atherosclerotic cardiovascular disease (ASCVD) in high-income countries is
mostly borne by the elderly. With increasing life expectancy, clear guidance on sensible use …

Objectives To determine the efficacy and safety of statins for primary prevention of
atherosclerotic cardiovascular disease (ASCVD) events in older adults, especially those …

BACKGROUND:: Although statins have been demonstrated to be beneficial for secondary
prevention in the elderly, their use for primary prevention has not been well described …

Cholesterol management in the elderly is challenging owing to competing risks for mortality,
potential for interactions with more complex medical regimens, and the importance of safety …

Background There remains uncertainty regarding optimal primary atherosclerotic
cardiovascular disease (ASCVD) prevention practices for older adults. Objective To assess …